Business

RavenQuest BioMed to Hold Third Quarter Conference Call

RavenQuest BioMed to Hold Third Quarter Conference Call.

articleRavenquest Biomed IncOctober 1, 20195/company/ravenquest-biomed-inc/news/ravenquest-biomed-to-hold-third-quarter-conference-call
RavenQuest BioMed to Hold Third Quarter Conference Call

About this update from Ravenquest Biomed Inc

[{"type":"text","content":"\n VANCOUVER, British Columbia, Oct. 01, 2019 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (CSE: RQB OTCQB: RVVQF Frankfurt: 1IT) (the “Company” or “RavenQuest”), one of Canada’s most innovative cannabis producers, announces it will hold a shareholder conference call on Wednesday, October 2 at 4:15pm ET / 1:15pm PT. RavenQuest CEO, George Robinson, will provide a company update, review recently released third quarter financials, and field questions from shareholders. Interested participants should follow the link below to register for the call: https://zoom.us/webinar/register/WN_inbZG8J2QeW5Zv_Pzene4A For more information, access RavenQuest’s investor presentation, fact sheet and videos here. Follow RavenQuest: Twitter:https://twitter.com/RQBGlobal Instagram: https://www.instagram.com/ravenquestbm/ Facebook:https://www.facebook.com/RavenQuest-BioMed-2355335751374131/?view_public_for=2355335751374131 LinkedIn:https://www.linkedin.com/company/ravenquest-biomed About RavenQuest BioMed Inc. RavenQuest BioMed Inc. is a diversified publicly traded cannabis company with divisions focused upon cannabis production, management services & consulting and specialized research & development. RavenQuest is a licensed producer with facilities located in Markham, Ontario and Edmonton, Alberta. RavenQuest maintains a research partnership with McGill University focused upon cultivar (strain) recognition, plant stabilization and yield maximization of the cannabis plant.  The Company focuses on partnerships with Indigenous communities. On Behalf of the Board of Directors ofRAVENQUEST BIOMED INC. “George Robinson” Chief Executive Officer For further information, please contact:           Mathieu McDonald, Corporate Communications1-877-282-1586 Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this press release, which has been prepared by management. Cautionary Note Regarding Forward-Looking Statements All statements in this press release, other than statements of historical fact, are \"forward-looking information\" with respect to the Company within the meaning of applicable sec...

More updates from Ravenquest Biomed Inc